13F-HR filed by Ally Bridge Group (NY) LLC
Ally Bridge Group (NY) LLC filed this 13F-HR for the quarter ended 2022-09-30, filed 2022-11-14, with 39 holding rows worth $151,465,000.
- Accession
- 0000950123-22-011716
- Filer
- CIK 1822947
- Filed
- 2022-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2022
A holdings report, 39 entries on the cover page, a total value of $151,465,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $151,465,000 with VALUE read as thousands by filing date, 13F file number 028-20834. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerFan Yu 028-20833
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SEAGEN INC | 81181C104 | COM | 92,506 | $12,658,000 | thousands by filing date | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 217,075 | $8,989,000 | thousands by filing date | |
| SANOFI SA SPONSORED ADR | 80105N105 | ADR | 230,000 | $8,745,000 | thousands by filing date | |
| KARYOPHARM THERAPEUTICS INC | 48576U106 | COM | 1,528,580 | $8,346,000 | thousands by filing date | |
| IRONWOOD PHARMACEUTICALS INC | 46333X108 | COMMON STOCK | 742,570 | $7,693,000 | thousands by filing date | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 479,506 | $7,653,000 | thousands by filing date | |
| GSK PLC SPONSORED ADR | 37733W204 | ADR | 255,000 | $7,505,000 | thousands by filing date | |
| AMARIN CORP PLC | 023111206 | SPONS ADR NEW | 6,358,288 | $6,931,000 | thousands by filing date | |
| ALKERMES PLC | G01767105 | SHS | 300,000 | $6,699,000 | thousands by filing date | |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 931,539 | $6,297,000 | thousands by filing date | |
| SYROS PHARMACEUTICALS INC | 87184Q206 | COM NEW | 868,403 | $5,593,000 | thousands by filing date | |
| HORIZON THERAPEUTICS PLC | G46188101 | SHS | 74,262 | $4,596,000 | thousands by filing date | |
| MEDAVAIL HOLDINGS INC | 58406B103 | COM | 5,894,897 | $4,574,000 | thousands by filing date | |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 377,000 | $4,516,000 | thousands by filing date | |
| SANA BIOTECHNOLOGY INC | 799566104 | COM | 735,250 | $4,412,000 | thousands by filing date | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 12,240 | $4,321,000 | thousands by filing date | |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 110,222 | $4,316,000 | thousands by filing date | |
| ALLAKOS INC | 01671P100 | COM | 598,172 | $3,661,000 | thousands by filing date | |
| ADICET BIO INC | 007002108 | COM | 244,400 | $3,475,000 | thousands by filing date | |
| LAKEFRONT BIOTHERAPEUTICS NV | 36315X101 | SPON ADR | 76,489 | $3,261,000 | thousands by filing date | |
| REPLIGEN CORP COM | 759916109 | Stock | 16,724 | $3,129,000 | thousands by filing date | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 204,014 | $3,044,000 | thousands by filing date | |
| ISOPLEXIS CORP | 465005106 | COM | 1,522,364 | $2,618,000 | thousands by filing date | |
| RAPID MICRO BIOSYSTEMS INC | 75340L104 | CLASS A COM | 699,664 | $2,260,000 | thousands by filing date | |
| ATEA PHARMACEUTICALS INC | 04683R106 | COMMON STOCK | 360,000 | $2,048,000 | thousands by filing date | |
| SCIENCE 37 HOLDINGS INC | 808644108 | COM | 1,266,512 | $2,039,000 | thousands by filing date | |
| WHITEHAWK THERAPEUTICS INC | 00032Q104 | CMN | 124,625 | $1,761,000 | thousands by filing date | |
| NAUTILUS BIOTECHNOLOGY INC | 63909J108 | COM | 823,974 | $1,747,000 | thousands by filing date | |
| INCYTE CORP COM | 45337C102 | Stock | 25,000 | $1,666,000 | thousands by filing date | |
| INTERCEPT PHARMACEUTICALS IN | 45845P108 | COM | 100,000 | $1,395,000 | thousands by filing date | |
| NEKTAR THERAPEUTICS | 640268108 | COM | 432,952 | $1,385,000 | thousands by filing date | |
| VOR BIOPHARMA INC | 929033108 | COM | 255,162 | $1,016,000 | thousands by filing date | |
| EDITAS MEDICINE INC | 28106W103 | COM | 82,900 | $1,015,000 | thousands by filing date | |
| CLOVIS ONCOLOGY INC | 189464100 | COM | 533,501 | $635,000 | thousands by filing date | |
| SELECTA BIOSCIENCES INC | 816212104 | COM | 334,255 | $548,000 | thousands by filing date | |
| MORPHOSYS AG | 617760202 | ADR | 95,031 | $478,000 | thousands by filing date | |
| CURIS INC | 231269200 | COM | 264,023 | $185,000 | thousands by filing date | |
| PUMA BIOTECHNOLOGY INC | 74587V107 | COMMON STOCK | 64,295 | $152,000 | thousands by filing date | |
| INFINITY PHARMACEUTICALS INC | 45665G303 | COM | 86,242 | $103,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000950123-22-011716 | this filing | 2022-11-14 | acceptance time not in the bulk data set |